Fishy 2017 amendment to §360. Registration of producers of drugs or devices

In 2017, US Federal Government amended an act that dealt with periodicity of inspections of US state entities that engage in the manufacture, preparation, propagation, compounding, or processing of a drug or device to a risk based inspection regime that considers that the entity is already being inspected by an international device audit program.